Skip to main content

Table 2 Stroke status and number of repeat medications (N = 1,424,378)

From: Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden

 

Stroke N (%)

No stroke N (%)

Unadjusted OR (95% CI) a

Age, gender and deprivation adjusted OR (95% CI) a

Age, gender, deprivation and morbidity count adjusted OR (95% CI) a

35690 (100)

1388688 (100)

Number of medications

     

None

2447 (6.9%)

863688 (62.2%)

1

1

1

One-two

3038 (8.5%)

240721 (17.3%)

4.45 (4.22 to 4.70)

2.38 (2.26 to 2.52)

2.29 (2.17 to 2.42)

Three-four

6566 (18.4%)

122518 (8.8%)

18.92 (18.05 to 19.82)

6.25 (5.95 to 6.57)

5.78 (5.49 to 6.08)

Five-six

8185 (22.9%)

75512 (5.4%)

38.26 (36.55 to 40.05)

10.50 (9.99 to 11.03)

9.36 (8.89 to 9.86)

Seven-eight

6721 (18.8%)

43344 (3.1%)

54.73 (52.20 to 57.38)

13.90 (13.20 to 14.63)

11.94 (11.29 to 12.62)

Nine-ten

4219 (11.8%)

22536 (1.6%)

66.08 (62.76 to 69.57)

16.22 (15.34 to17.15)

13.44 (12.65 to 14.29)

Eleven or more

4514(12.6%)

20369 (1.5%)

78.22 (74.32 to 82.32)

20.13 (19.05 to 21.27)

15.84 (14.86 to 16.88)

  1. aall p < 0.001.